{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:23:12Z","timestamp":1793892192468,"version":"4.8.0"},"reference-count":98,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An Alzheimer's disease (AD) diagnosis made in the earliest symptomatic stages substantially benefits patients and their care partners. However, little is known regarding the clinical, healthcare system-level, and patient-specific barriers that hinder timely diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore real-world practices surrounding the diagnostic journey and management of mild cognitive impairment (MCI)\/AD dementia patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were drawn from Adelphi Real World Dementia Disease Specific Programme\u2122, a cross-sectional survey of physicians treating MCI\/AD dementia patients in France, Germany, Italy, Spain, the United Kingdom, the United States, and Japan between 2022 and 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 779 physicians reported data on 5551 patients. Physicians indicated current disease severity for 5421 patients; 37.2% had MCI (87.3% with suspected prodromal AD and 12.7% undetermined etiology), 17.2% AD with mild dementia, 31.1% AD with moderate dementia, and 14.5% AD with severe dementia. When not immediately diagnosed\n                      <jats:bold>,<\/jats:bold>\n                      the median time from first consultation to initial diagnosis was 8.9 and 12.6 weeks when patients first consulted and were diagnosed by either a primary care practitioner (PCP) or a specialist, respectively, compared with 21.6 weeks when a PCP referred to a specialist for diagnosis. Diagnostic delays were predominantly due to specialist wait times. Few patients had diagnostic AD biomarker tests (cerebrospinal fluid testing 9.5%, amyloid positron emission tomography 3.7%, AD-blood tests 5.3%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Timely MCI and AD diagnosis is impeded by referral delays and limited use of biomarker testing. Addressing these critical care gaps requires enhanced physician training, reduced wait times and increased biomarker utilization for early management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877251322978","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T18:49:00Z","timestamp":1742496540000},"page":"1212-1234","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey"],"prefix":"10.1177","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-5661","authenticated-orcid":false,"given":"Simona Z","family":"Vasileva-Metodiev","sequence":"first","affiliation":[{"name":"Eli Lilly &amp; Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-9614","authenticated-orcid":false,"given":"Drew","family":"Spargo","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3852-5537","authenticated-orcid":false,"given":"Eric G","family":"Klein","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1467-6880","authenticated-orcid":false,"given":"Frances-Catherine","family":"Quevenco","sequence":"additional","affiliation":[{"name":"Eli Lilly &amp; Company, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-6345","authenticated-orcid":false,"given":"Sarah","family":"Cotton","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Sanchez-Juan","sequence":"additional","affiliation":[{"name":"Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-8167","authenticated-orcid":false,"given":"Yoshiki","family":"Niimi","sequence":"additional","affiliation":[{"name":"Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-0008","authenticated-orcid":false,"given":"Nicole R.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA"},{"name":"Indiana University Center for Aging Research, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.937486"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13809"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567205012666150701103107"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170116143743"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030453"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70291-0"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.9.1133"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31824b211b"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-504X.2005.00480.x"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.9.1143"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb02571.x"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.2.226"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000313"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.131"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afv020"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1471301214548520"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000511233"},{"key":"e_1_3_5_27_2","article-title":"Geographic variation in shortfalls of dementia specialists in the United States","volume":"2","author":"Liu JL","year":"2024","unstructured":"Liu JL, Baker L, Chen AY, et al. Geographic variation in shortfalls of dementia specialists in the United States. Health Aff Sch 2024; 2: qxae088.","journal-title":"Health Aff Sch"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008259"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13244"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2012.03991.x"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.01.002"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/423265"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58070906"},{"key":"e_1_3_5_34_2","first-page":"123","article-title":"Alzheimer\u2019s disease\u2013why we need early diagnosis","volume":"9","author":"Rasmussen J","year":"2019","unstructured":"Rasmussen J, Langerman H. Alzheimer\u2019s disease\u2013why we need early diagnosis. Degen Neurol Neuromuscul Dis 2019; 9: 123\u2013130.","journal-title":"Degen Neurol Neuromuscul Dis"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2015.11.005"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2021.23"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-179920"},{"key":"e_1_3_5_38_2","article-title":"Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers","volume":"58","author":"Whitlatch CJ","year":"2018","unstructured":"Whitlatch CJ, Orsulic-Jeras S. Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers. Gerontologist 2018; 58: S58\u2013S73.","journal-title":"Gerontologist"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.43"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00471-5"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13764"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51863"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00504-6"},{"key":"e_1_3_5_44_2","article-title":"Dementia care navigation: building toward a common definition, key principles, and outcomes","volume":"9","author":"Kallmyer BA","year":"2023","unstructured":"Kallmyer BA, Bass D, Baumgart M, et al. Dementia care navigation: building toward a common definition, key principles, and outcomes. Alzheimers Dement (N Y) 2023; 9: e12408.","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_3_5_45_2","first-page":"3063","article-title":"Real-world physician and patient behaviour across countries: Disease-Specific Programmes\u2013a means to understand","volume":"24","author":"Anderson P","year":"2008","unstructured":"Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific Programmes\u2013a means to understand. CMRO 2008; 24: 3063\u20133072.","journal-title":"CMRO"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S120101"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2279679"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_3_5_50_2","unstructured":"National Institute for Health and Clinical Excellence. Health Technology Appraisal: Donepezil galantamine rivastigmine and memantine for the treatment of mild to moderate Alzheimer's disease https:\/\/www.nice.org.uk\/guidance\/TA217\/documents\/alzheimers-disease-mild-to-moderate-donepezil-galantamine-rivastigmine-and-memantine-part-review-draft-scope2 (2009 accessed January 16 2024)."},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0609-7"},{"key":"e_1_3_5_52_2","unstructured":"European Pharmaceutical Market Research Association. Code of conduct https:\/\/www.ephmra.org\/sites\/default\/files\/2022-08\/EPHMRA%202022%20Code%20of%20Conduct.pdf (2022 accessed November 14 2023)."},{"key":"e_1_3_5_53_2","first-page":"191","article-title":"Health insurance portability and accountability act of 1996","volume":"104","author":"United States Congress","year":"1996","unstructured":"United States Congress. Health insurance portability and accountability act of 1996. Public Law 1996; 104: 191.","journal-title":"Public Law"},{"key":"e_1_3_5_54_2","volume-title":"Health Information Technology for Economic and Clinical Health Act","author":"United States Department of Health and Human Services","year":"2010","unstructured":"United States Department of Health and Human Services. Health Information Technology for Economic and Clinical Health Act. Washington, DC: United States Department of Health and Human Services, 2010."},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01212-0"},{"key":"e_1_3_5_56_2","article-title":"Alzheimer's disease diagnosis and management: perspectives from around the world","volume":"14","author":"Kerwin D","year":"2022","unstructured":"Kerwin D, Abdelnour C, Caramelli P, et al. Alzheimer's disease diagnosis and management: perspectives from around the world. Alzheimers Dis (Amst) 2022; 14: e12334.","journal-title":"Alzheimers Dis (Amst)"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012111"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2019.07.005"},{"key":"e_1_3_5_59_2","first-page":"391","article-title":"2020 Alzheimer\u2019s disease facts and figures; Special Report \u2014 On the front lines: primary care physicians and Alzheimer's care in America","volume":"16","author":"Alzheimer's Association","year":"2020","unstructured":"Alzheimer's Association. 2020 Alzheimer\u2019s disease facts and figures; Special Report \u2014 On the front lines: primary care physicians and Alzheimer's care in America. Alzheimers Dement 2020; 16: 391.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4603-2"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12068"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-020-00498-y"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1080\/028134301300034620"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1177\/1533317518791401"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa228"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.85"},{"key":"e_1_3_5_67_2","first-page":"4942562","article-title":"Physician practice patterns associated with diagnostic evaluation of patients with suspected mild cognitive impairment and Alzheimer's disease","volume":"2019","author":"Judge D","year":"2019","unstructured":"Judge D, Roberts J, Khandker RK, et al. Physician practice patterns associated with diagnostic evaluation of patients with suspected mild cognitive impairment and Alzheimer's disease. Int J Alzheimers Dis 2019; 2019: 4942562.","journal-title":"Int J Alzheimers Dis"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13651"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00066-1"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbas.2023.100093"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13676"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1177\/08919887221141651"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.13855"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3181a6bebc"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200932"},{"key":"e_1_3_5_76_2","unstructured":"United States Food and Drug Administration. Prescribing information for LEQEMBI (lecanemab-irmb) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761269s000lbl.pdf (2023 accessed July 3 2024)."},{"key":"e_1_3_5_77_2","unstructured":"United States Food and Drug Administration. Prescribing information for KISUNLA (donanemab-azbt) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761248s000lbl.pdf (2024 accessed July 3 2024)."},{"key":"e_1_3_5_78_2","unstructured":"United Kingdom Medicine & Healthcare Products Regulatory Agency. Donanemab: Summary of product characteristics https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/940882a3f371c1a69be326e3d993c1ec4582005e (2024 accessed December 12 2024)."},{"key":"e_1_3_5_79_2","unstructured":"United Kingdom Medicine & Healthcare Products Regulatory Agency. Lecanemab: Summary of product characteristics https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/8c386e8ff40d92a383d0bc4efb2ce7325b61f88b (2024 accessed December 12 2024)."},{"key":"e_1_3_5_80_2","unstructured":"Japan Pharmaceuticals and Medical Devices Agency. List of approved products https:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/approved-information\/drugs\/0002.html (2024 accessed August 28 2024)."},{"key":"e_1_3_5_81_2","unstructured":"United Arab Emirates Ministry of Health and Prevention. Product marketing authorization approval: Kisunla\u2122 350mg\/20mL https:\/\/smartservices.moh.gov.ae\/eReports\/downloadCertificate?appNumber=0F6A88C55CC68BAD01E74FB0611B9875 (2024 accessed September 1 2024)."},{"key":"e_1_3_5_82_2","unstructured":"United Arab Emirates Ministry of Health and Prevention. Registered medicinal product directory https:\/\/mohap.gov.ae\/en\/services\/registered-medical-product-directory (2024 accessed September 1 2024)."},{"key":"e_1_3_5_83_2","unstructured":"China National Medical Products Administration. Lecanemab injection approved for marketing by China NMPA https:\/\/english.nmpa.gov.cn\/2024-01\/09\/c_986552.htm (2024 accessed August 28 2024)."},{"key":"e_1_3_5_84_2","unstructured":"South Korea Ministry of Food and Drug Safety. Integrated drug information system drug product information details-lecanemab https:\/\/nedrug.mfds.go.kr\/pbp\/CCBBB01\/getItemDetailCache?cacheSeq=202401277aupdateTs2024-11-22%2018:30:49.725263b (2024 accessed December 12 2024)."},{"key":"e_1_3_5_85_2","unstructured":"The Government of the Hong Kong Special Administrative Region. Registered pharmaceutical products https:\/\/www.drugoffice.gov.hk\/eps\/do\/en\/pharmaceutical_trade\/news_informations\/reListRPP.html?srtRange=LA&ndRange=LZ (2024 accessed November 27 2024)."},{"key":"e_1_3_5_86_2","unstructured":"Ministry of Health Israel. LEQEMBI prescribing information \u05de\u05d0\u05d2\u05e8 \u05d4\u05ea\u05e8\u05d5\u05e4\u05d5\u05ea (2024 accessed November 27 2024)."},{"key":"e_1_3_5_87_2","unstructured":"European Medicines Agency. Leqembi: Summary of opinion (initial authorisation) https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-leqembi_en.pdf (2024 accessed November 15 2024)."},{"key":"e_1_3_5_88_2","article-title":"Urgency to treat before it\u2019s too late: daily transitions to mild or moderate AD dementia in the US and Europe","volume":"8","author":"Gillis C","year":"2021","unstructured":"Gillis C, Nejati M, Thompson R, et al. Urgency to treat before it\u2019s too late: daily transitions to mild or moderate AD dementia in the US and Europe. J Prev Alzheimers Dis 2021; 8: S146.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00269-x"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02988-7"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000001577"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.9907"},{"key":"e_1_3_5_93_2","unstructured":"Centers for Medicare and Medicaid Services. Program statistics - medicare total enrollment tables https:\/\/data.cms.gov\/summary-statistics-on-beneficiary-enrollment\/medicare-and-medicaid-reports\/cms-program-statistics-medicare-total-enrollment (2021 accessed December 12 2024)."},{"key":"e_1_3_5_94_2","unstructured":"United Kingdom Office for National Statistics. Ethnic group England and Wales: Census 2021 https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/culturalidentity\/ethnicity\/bulletins\/ethnicgroupenglandandwales\/census2021 (2021)."},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S152647"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40609-016-0073-1"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00404-2"},{"key":"e_1_3_5_98_2","unstructured":"United States Department of Health and Human Services. National plan to address Alzheimer\u2019s disease: 2013 update http:\/\/aspe.hhs.gov\/daltcp\/napa\/NatlPlan2013.shtml (2013 accessed December 12 2024)."},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0288"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251322978","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877251322978","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251322978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:10:06Z","timestamp":1777371006000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877251322978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/13872877251322978"],"URL":"https:\/\/doi.org\/10.1177\/13872877251322978","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}